Abstract:Background Currently, some studies have demonstrated that miR-34a could serve as a suppressor of several cancers including hepatocellular carcinoma (HCC). Previously, we discovered that miR-34a was downregulated in HCC and involved in the tumorigenesis and progression of HCC; however, the mechanism remains unclear. The purpose of this study was to estimate the expression of miR-34a in HCC by applying the microarray profiles and analyzing the predicted targets of miR-34a and their related biological pathways of HCC. Methods Gene expression omnibus (GEO) datasets were conducted to identify the difference of miR-34a expression between HCC and corresponding normal tissues and to explore its relationship with HCC clinicopathologic features. The natural language processing (NLP), gene ontology (GO), pathway and network analyses were performed to analyze the genes associated with the carcinogenesis and progression of HCC and the targets of miR-34a predicted in silico. In addition, the integrative analysis was performed to explore the targets of miR-34a which were also relevant to HCC. Results The analysis of GEO datasets demonstrated that miR-34a was downregulated in HCC tissues, and no heterogeneity was observed (Std. Mean Difference(SMD) = 0.63, 95% confidence intervals(95%CI):[0.38, 0.88], P < 0.00001; P heterogeneity = 0.08 I 2 = 41%). However, no association was found between the expression value of miR-34a and any clinicopathologic characteristics. In the NLP analysis of HCC, we obtained 25 significant HCC-associated signaling pathways. Besides, we explored 1000 miR-34a-related genes and 5 significant signaling pathways in which CCND1 and Bcl-2 served as necessary hub genes. In the integrative analysis, we found 61 hub genes and 5 significant pathways, including cell cycle, cytokine-cytokine receptor interaction, notching pathway, p53 pathway and focal adhesion, which proposed the relevant functions of miR-34a in HCC. Conclusion Our results may lead researchers to understand the molecular mechanism of miR-34a in the diagnosis, prognosis and therapy of HCC. Therefore, the interaction between miR-34a and its targets may promise better prediction and treatment for HCC. And the experiments in vivo and vitro will be conducted by our group to identify the specific mechanism of miR-34a in the progress and deterioration of HCC.

Systematic Analysis of Intestinal MicroRNAs Expression in HCC: Identification of Suitable Reference Genes in Fecal Samples

Identification of the typical miRNAs and target genes in hepatocellular carcinoma.

Identification of Reference Genes for Circulating Microrna Analysis in Colorectal Cancer

Identification And Validation Of Reference Genes For Qpcr Detection Of Serum Micrornas In Colorectal Adenocarcinoma Patients

Circulating MicroRNA Panel As a Diagnostic Marker for Hepatocellular Carcinoma

Identification of Mir-23A As a Novel Microrna Normalizer for Relative Quantification in Human Uterine Cervical Tissues

MicroRNA Profile in HBV-induced Infection and Hepatocellular Carcinoma.

Profiling and Integrated Analysis of Differentially Expressed MicroRNAs as Novel Biomarkers of Hepatocellular Carcinoma

Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance

Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.

Identification of Differentially Expressed MicroRNAs involved in the Pathogenesis of Colorectal Cancer.

Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.

Evaluation and Validation of Suitable Reference Genes for Reverse Transcription-Quantitative Polymerase Chain Reaction Studies in Cholangiocarcinoma Patients and Cell Lines.

Identification of Novel Biomarkers for Hepatocellular Carcinoma Using Transcriptome Analysis.

In Silico Analysis of MicroRNA Expression Data in Liver Cancer

Microarray Analysis of Microrna Expression in Hepatocellular Carcinoma and Non-Tumorous Tissues Without Viral Hepatitis.

Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma

Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma

Identification and validation of suitable reference genes for the investigation of serum microRNA in bladder cancer patients

Identification of reference genes and miRNAs for qRT-PCR in human esophageal squamous cell carcinoma

Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis